These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3011551)

  • 1. Strategies for the inhibition of neuropeptide-metabolizing enzymes.
    Turner AJ
    Biochem Soc Trans; 1986 Apr; 14(2):399-401. PubMed ID: 3011551
    [No Abstract]   [Full Text] [Related]  

  • 2. Are there neuropeptide-specific peptidases?
    Turner AJ; Matsas R; Kenny AJ
    Biochem Pharmacol; 1985 May; 34(9):1347-56. PubMed ID: 2986644
    [No Abstract]   [Full Text] [Related]  

  • 3. Intramembrane proteolysis.
    Wolfe MS
    Chem Rev; 2009 Apr; 109(4):1599-612. PubMed ID: 19226105
    [No Abstract]   [Full Text] [Related]  

  • 4. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
    Checler F; Vincent JP; Kitabgi P
    J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of neuropeptides. Neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme).
    Hooper NM; Kenny AJ; Turner AJ
    Biochem J; 1985 Oct; 231(2):357-61. PubMed ID: 2998348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of neuropeptides at brain and pituitary sites.
    Edwardson JA; McDermott JR
    Biochem Soc Trans; 1985 Feb; 13(1):50-3. PubMed ID: 3888723
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropeptide-metabolizing peptidases in neuro-2a neuroblastoma and C6 glioma cells.
    Del Bel EA; Gambarini AG; Martins AR
    J Neurochem; 1986 Sep; 47(3):938-44. PubMed ID: 3016193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hatching enzyme of the solitary Ascidian, Halocynthia roretzi.
    Hoshi M; Numakunai T
    Acta Embryol Morphol Exp (Halocynthia Assoc); 1981 Dec-1982 Jan; 2(3):163-9. PubMed ID: 6756008
    [No Abstract]   [Full Text] [Related]  

  • 9. Common feature of the four types of protease mechanism.
    Polgár L
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():327-31. PubMed ID: 2205242
    [No Abstract]   [Full Text] [Related]  

  • 10. Mammalian metalloendopeptidases.
    Bond JS; Beynon RJ
    Int J Biochem; 1985; 17(5):565-74. PubMed ID: 3896890
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
    Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic inactivation of substance P and neurokinin A in the longitudinal muscle layer of guinea pig small intestine.
    Nau R; Schäfer G; Deacon CF; Cole T; Agoston DV; Conlon JM
    J Neurochem; 1986 Sep; 47(3):856-64. PubMed ID: 2426410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.
    Robl JA; Cimarusti MP; Simpkins LM; Brown B; Ryono DE; Bird JE; Asaad MM; Schaeffer TR; Trippodo NC
    J Med Chem; 1996 Jan; 39(2):494-502. PubMed ID: 8558518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer.
    Parvathy S; Oppong SY; Karran EH; Buckle DR; Turner AJ; Hooper NM
    Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):37-43. PubMed ID: 9355732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioedema with renin angiotensin system drugs and neutral endopeptidase inhibitors.
    Kostis JB; Moreyra AE; Kostis WJ
    J Am Soc Hypertens; 2016 May; 10(5):387-9. PubMed ID: 27005996
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening of selected basidiomycetes for inhibitory activity on neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE).
    Melzig MF; Pieper S; Siems WE; Heder G; Bóttger A; Liberra K; Lindequist U
    Pharmazie; 1996 Jul; 51(7):501-3. PubMed ID: 8774843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of bradykinin by peptidases in the lung.
    Dragović T; Igić R; Erdös EG; Rabito SF
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1491-6. PubMed ID: 8389109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biochemistry of the proteinases of eucaryotic microorganisms.
    North MJ
    Microbiol Rev; 1982 Sep; 46(3):308-40. PubMed ID: 6813664
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation and metabolism of neuropeptides.
    McKelvy JF; Blumberg S
    Annu Rev Neurosci; 1986; 9():415-34. PubMed ID: 2423009
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
    Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.